Aileen Rubio

1.9k total citations
33 papers, 1.6k citations indexed

About

Aileen Rubio is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Aileen Rubio has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Infectious Diseases and 8 papers in Pharmacology. Recurrent topics in Aileen Rubio's work include Antimicrobial Resistance in Staphylococcus (13 papers), Bacterial biofilms and quorum sensing (11 papers) and Antibiotic Resistance in Bacteria (8 papers). Aileen Rubio is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (13 papers), Bacterial biofilms and quorum sensing (11 papers) and Antibiotic Resistance in Bacteria (8 papers). Aileen Rubio collaborates with scholars based in United States, Australia and Canada. Aileen Rubio's co-authors include Arnold S. Bayer, Nagendra N. Mishra, Soo‐Jin Yang, Kit Pogliano, Cynthia C. Nast, Xin Jiang, Michael R. Yeaman, Jared Silverman, Robert C. Moellering and David R. Cameron and has published in prestigious journals such as Genes & Development, The EMBO Journal and PLoS ONE.

In The Last Decade

Aileen Rubio

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aileen Rubio United States 22 880 856 394 305 285 33 1.6k
Poochit Nonejuie United States 24 642 0.7× 724 0.8× 395 1.0× 163 0.5× 424 1.5× 42 1.7k
Niles P. Donegan United States 21 1.2k 1.4× 862 1.0× 353 0.9× 597 2.0× 92 0.3× 29 2.0k
Christoph M. Ernst Germany 13 629 0.7× 389 0.5× 359 0.9× 147 0.5× 107 0.4× 17 1.1k
Asher Brauner Israel 5 608 0.7× 276 0.3× 474 1.2× 358 1.2× 90 0.3× 6 1.3k
Xenia Kostoulias Australia 20 848 1.0× 344 0.4× 689 1.7× 159 0.5× 89 0.3× 36 1.6k
Steve N. Leonard United States 11 458 0.5× 499 0.6× 229 0.6× 134 0.4× 256 0.9× 11 937
Marat R. Sadykov United States 27 1.4k 1.6× 937 1.1× 149 0.4× 542 1.8× 109 0.4× 45 1.9k
Q. C. Truong-Bolduc United States 18 640 0.7× 698 0.8× 507 1.3× 194 0.6× 80 0.3× 29 1.1k
Thanh T. Luong United States 21 1.4k 1.6× 1.3k 1.6× 141 0.4× 491 1.6× 119 0.4× 28 1.8k
Choon Kim United States 17 674 0.8× 488 0.6× 386 1.0× 190 0.6× 129 0.5× 40 1.1k

Countries citing papers authored by Aileen Rubio

Since Specialization
Citations

This map shows the geographic impact of Aileen Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen Rubio more than expected).

Fields of papers citing papers by Aileen Rubio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aileen Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen Rubio. The network helps show where Aileen Rubio may publish in the future.

Co-authorship network of co-authors of Aileen Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Aileen Rubio. A scholar is included among the top collaborators of Aileen Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aileen Rubio. Aileen Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cotroneo, Nicole, et al.. (2024). Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. Journal of Antimicrobial Chemotherapy. 79(4). 875–882. 9 indexed citations
2.
Rubio, Aileen, et al.. (2023). A monoclonal antibody 4G2 exhibits anti-viral activity in mouse models of chronic hepatitis B. Journal of Hepatology. 78. S1164–S1164.
3.
Brouillette, Éric, et al.. (2019). In Vitro Activity of Tebipenem (SPR859) against Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria. Antimicrobial Agents and Chemotherapy. 63(4). 18 indexed citations
4.
Mendes, Rodrigo E., Paul R. Rhomberg, Troy Lister, et al.. (2019). Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens. Microbial Drug Resistance. 26(4). 319–328. 10 indexed citations
5.
Brown‐Elliott, Barbara A., Aileen Rubio, & Richard J. Wallace. (2018). In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria. Antimicrobial Agents and Chemotherapy. 62(11). 47 indexed citations
6.
7.
Bayer, Arnold S., Nagendra N. Mishra, Ambrose L. Cheung, Aileen Rubio, & Soo‐Jin Yang. (2016). Dysregulation ofmprFanddltABCDexpression among daptomycin-non-susceptible MRSA clinical isolates. Journal of Antimicrobial Chemotherapy. 71(8). 2100–2104. 33 indexed citations
8.
Cano, Carlos, et al.. (2016). Perception of health-related quality of life using the EURO-QOL in older adults in Bogotá, Colombia. European Geriatric Medicine. 7(4). 340–345. 7 indexed citations
9.
Cameron, David R., Lawrence I. Mortin, Aileen Rubio, et al.. (2015). Impact of daptomycin resistance onStaphylococcus aureusvirulence. Virulence. 6(2). 127–131. 33 indexed citations
10.
11.
Song, Yang, Aileen Rubio, Radheshyam K. Jayaswal, Jared Silverman, & Brian J. Wilkinson. (2013). Additional Routes to Staphylococcus aureus Daptomycin Resistance as Revealed by Comparative Genome Sequencing, Transcriptional Profiling, and Phenotypic Studies. PLoS ONE. 8(3). e58469–e58469. 47 indexed citations
12.
Rubio, Aileen, et al.. (2012). LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates ofStaphylococcus aureuswith mutations inmprF. Molecular Membrane Biology. 29(1). 1–8. 27 indexed citations
13.
Peleg, Anton Y., Spiros Miyakis, Doyle V. Ward, et al.. (2012). Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus. PLoS ONE. 7(1). e28316–e28316. 192 indexed citations
14.
Mishra, Nagendra N., James A. McKinnell, Michael R. Yeaman, et al.. (2011). In Vitro Cross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates. Antimicrobial Agents and Chemotherapy. 55(9). 4012–4018. 108 indexed citations
15.
Rubio, Aileen, Mary Conrad, Robert J. Haselbeck, et al.. (2010). Regulation of mprF by Antisense RNA Restores Daptomycin Susceptibility to Daptomycin-Resistant Isolates of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 55(1). 364–367. 36 indexed citations
16.
Julian, Kathleen G., Klaudia Kosowska-Shick, Cynthia Whitener, et al.. (2007). Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis. Antimicrobial Agents and Chemotherapy. 51(9). 3445–3448. 106 indexed citations
17.
Jiang, Xin, Aileen Rubio, Shinobu Chiba, & Kit Pogliano. (2005). Engulfment‐regulated proteolysis of SpoIIQ: evidence that dual checkpoints control σK activity. Molecular Microbiology. 58(1). 102–115. 35 indexed citations
18.
Jiang, Xin, et al.. (2004). Zipper-like interaction between proteins in adjacent daughter cells mediates protein localization. Genes & Development. 18(23). 2916–2928. 89 indexed citations
19.
Rubio, Aileen & Kit Pogliano. (2004). Septal localization of forespore membrane proteins during engulfment in Bacillus subtilis. The EMBO Journal. 23(7). 1636–1646. 46 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Poochit Nonejuie Breakdown of academic impact, for papers by Niles P. Donegan Breakdown of academic impact, for papers by Christoph M. Ernst Breakdown of academic impact, for papers by Asher Brauner Breakdown of academic impact, for papers by Xenia Kostoulias Breakdown of academic impact, for papers by Steve N. Leonard Breakdown of academic impact, for papers by Marat R. Sadykov Breakdown of academic impact, for papers by Q. C. Truong-Bolduc Breakdown of academic impact, for papers by Thanh T. Luong Breakdown of academic impact, for papers by Choon Kim
Rankless by CCL
2026